Live Chat

CFD's zijn complexe instrumenten en gaan gepaard met een hoog risico snel kapitaal te verliezen als gevolg van hefboommechanismen. 74% an de retailbeleggers lijdt verlies op de handel in CFD's met deze aanbieder. U dient zorgvuldig te overwegen of u begrijpt hoe CFD's werken en of u het zich kunt veroorloven om hoge risico's te nemen op het verliezen van uw kapitaal.

Close

Handelen Bristol Myers BMY

BristolMyers live grafieken

instrument_fundamentals

Weekly Search
Weekly
Daily
Datum Sluit Verandering % verandering Openen Piek Bodem

Info

Spread

0.33

Spread (%)

0.6221 %

Hefboom

1:5

Dagrente kopen

-0.0597 %

Dagrente verkopen

-0.0292 %

Valuta

USD

Openingstijden

Markt gesloten

Maandag

13:31 - 19:59

Dinsdag

13:31-19:59

Woensdag

13:31-19:59

Donderdag

13:31-19:59

Vrijdag

13:31-19:59

instr__analysis_statistics

Openen

---

Vorige Sluiten

---

52-weekse hoog/laag

--- – ---

Beurswaarde

113476673536

Uitstaande aandelen

2028179968

Datum winstcijfer (volgende)

2001-08-07

Div. rend.

2024-11-01

Ex-dividenddatum

2024-10-04

Jaarlijks verwachte dividendpercentage

2.4

Jaarlijks verwachte dividendrendement

0.0433

Winst per aandeel

-3.61

Meer informatie over dit instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Gerelateerde instrumenten

Activa
Verkoop
Koop
% verandering
Gerelateerde instrumenten

Laatste marktnieuws

Blijf op de hoogte van het laatste financiële nieuws uit de hele wereld.

Woensdag, 6 November 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

Dinsdag, 5 November 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

Dinsdag, 5 November 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

Dinsdag, 5 November 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

Dinsdag, 5 November 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

Dinsdag, 5 November 2024

Early Election Results Shift Markets as Trump’s Chances Rise

Maandag, 4 November 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

Maandag, 4 November 2024

US election: What will happen to tesla stock if Trump wins?

Trustpilot
Live Chat